Farrugia, M.K.; Long, M.D.; Mattson, D.M.; Flaherty, L.T.; Dong, B.; Cortes Gomez, E.; Wei, L.; Witkiewicz, A.K.; Yao, S.; Kalinski, P.;
et al. Concurrent Aspirin Use Is Associated with Improved Outcome in Rectal Cancer Patients Who Undergo Chemoradiation Therapy. Cancers 2021, 13, 205.
https://doi.org/10.3390/cancers13020205
AMA Style
Farrugia MK, Long MD, Mattson DM, Flaherty LT, Dong B, Cortes Gomez E, Wei L, Witkiewicz AK, Yao S, Kalinski P,
et al. Concurrent Aspirin Use Is Associated with Improved Outcome in Rectal Cancer Patients Who Undergo Chemoradiation Therapy. Cancers. 2021; 13(2):205.
https://doi.org/10.3390/cancers13020205
Chicago/Turabian Style
Farrugia, Mark K., Mark D. Long, David M. Mattson, Leayn T. Flaherty, Bowen Dong, Eduardo Cortes Gomez, Lei Wei, Agnieszka K. Witkiewicz, Song Yao, Pawel Kalinski,
and et al. 2021. "Concurrent Aspirin Use Is Associated with Improved Outcome in Rectal Cancer Patients Who Undergo Chemoradiation Therapy" Cancers 13, no. 2: 205.
https://doi.org/10.3390/cancers13020205
APA Style
Farrugia, M. K., Long, M. D., Mattson, D. M., Flaherty, L. T., Dong, B., Cortes Gomez, E., Wei, L., Witkiewicz, A. K., Yao, S., Kalinski, P., & Singh, A. K.
(2021). Concurrent Aspirin Use Is Associated with Improved Outcome in Rectal Cancer Patients Who Undergo Chemoradiation Therapy. Cancers, 13(2), 205.
https://doi.org/10.3390/cancers13020205